On behalf of the board of 13 Seeds Ltd (Company or 13 Seeds), I am pleased to present this Prospectus and to invite
you to become a shareholder in the Company.
As a result of the legalisation of hemp food products under Australian law in November 2017, and subject to the
Company successfully completing the Public Offer, the Board is enthusiastic about its future.
13 Seeds is an Australian hemp food and nutraceutical company established in 2016 and based in Tasmania. The
Company sources high-quality hemp seeds for processing by third parties and then distributes its products online
(through its own website and other affiliate websites) and via its nationwide distribution partners.
With over 20 existing products across its gourmet food and skin care ranges, the Company has one of the widest
ranges of hemp food and nutraceutical products in the Australian hemp market and are able to leverage its access
to a large percentage of non-major supermarkets, independent grocers, and health food stores across Australia.
13 Seeds has the regulatory approvals it requires to conduct all aspects of its current hemp food business in
Australia. Whilst the Company currently relies on third parties to grow and process its hemp supplies and undertake
a portion of its manufacturing, the final manufacture, packaging and quality control for products (excluding hemp
oil and cosmetics) is done in-house.
The Company will continue to source and secure a sustainable supply of high-quality hemp seeds direct from
Tasmanian farms and seed companies and is ideally positioned to do so given the Company’s geographic location
and market status in Tasmania.
13 Seeds’ current distribution agreements provide its products with access to stores across Australia, including
independent grocers, health food stores and pharmacies. The Company currently sells its products within Australia.
All of the above leaves the Company exceptionally well positioned to capitalise on rising consumer awareness about
the benefits of plant-based protein, and in particular the benefits of hemp protein.
The Directors are of the view that an investment in the Company provides the following non-exhaustive list of advantages:
(a) product ready and revenue generating across existing online and in-store distribution channels (please see
section 6 for further information of the Company’s financial position);
(b) favourable industry focus (please see section 3 for further detail); and
(c) an experienced fast-moving consumer goods (FMCG) executive team to drive future growth (please see
section 5 for further detail).
The purpose of the Public Offer is to raise up to $6,000,000 (before associated costs) by the issue of up to
30,000,000 Shares at an issue price of $0.20 each. The Lead Manager of the Public Offer is PAC Partners (see Section
7.1 for further details).
The proceeds of the Public Offer will be utilised to enable the Company to continue to manufacture and sell a suite
of wholesale hemp products, and innovative retail hemp food products to continue to grow its existing revenues.
Proceeds will also provide general working capital and pay for the costs of the Offers. Investors should note that the
Company is currently operating at a loss, is at an early stage of development and that accordingly, an investment in
the Company should be considered highly speculative.
This Prospectus contains detailed information about the Offers and the current and proposed operations of the
Company, as well as the risks pertaining to an investment in the Company. Potential investors in the Company should
carefully consider those risks (detailed in Section 4).
We look forward to welcoming you as a Shareholder should you decide to take up Securities pursuant to the Offers.